Skip to main content

Advertisement

Springer Nature Link
Log in

Melanoma in Pregnancy: Therapeutic Challenges

  • Pregnancy Dermatoses and Fetal Exposure (A Ingber and Y Ramot, Section Editors)
  • Published:
Current Dermatology Reports Aims and scope Submit manuscript

Abstract

Cancer-complicating pregnancy is a rare coexistence. The therapeutic management of the pregnant patient with cancer is especially difficult because it involves two persons, the mother and the fetus. Malignant melanoma is one of the more common cancers affecting women in childbearing years. In this report, we discuss the therapeutic challenges when treating a pregnant patient diagnosed with malignant melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–49.

    Article  PubMed  Google Scholar 

  2. Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control. 2008;19(5):437–42.

    Article  PubMed  Google Scholar 

  3. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44.

    Article  PubMed  Google Scholar 

  4. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 2009;38(3):814–30.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer. 2005;41(1):45–60.

    Article  PubMed  Google Scholar 

  6. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14):2040–59.

    Article  PubMed  Google Scholar 

  7. PACK GT, SCHARNAGEL IM. The prognosis for malignant melanoma in the pregnant woman. Cancer. 1951;4(2):324–34.

    Article  CAS  PubMed  Google Scholar 

  8. Shiu MH, Schottenfeld D, Maclean B, Fortner JG. Adverse effect of pregnancy on melanoma: a reappraisal. Cancer. 1976;37(1):181–7.

    Article  CAS  PubMed  Google Scholar 

  9. Stensheim H, Møller B, van Dijk T, Fosså SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009;27(1):45–51.

    Article  PubMed  Google Scholar 

  10. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol. 2004;22(21):4369–75.

    Article  PubMed  Google Scholar 

  11. O’Meara AT, Cress R, Xing G, Danielsen B, Smith LH. Malignant melanoma in pregnancy. A population-based evaluation. Cancer. 2005;103(6):1217–26.

    Article  PubMed  Google Scholar 

  12. Gandini S, Iodice S, Koomen E, Di Pietro A, Sera F, Caini S. Hormonal and reproductive factors in relation to melanoma in women: current review and meta-analysis. Eur J Cancer. 2011;47(17):2607–17. Important meta-analysis and conclusions regarding hormonal factors and risk for melanoma.

    Article  CAS  PubMed  Google Scholar 

  13. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Elder DE. Thin melanoma. Arch Pathol Lab Med. 2011;135(3):342–6.

    PubMed  Google Scholar 

  16. Khera SY, Kiluk JV, Hasson DM, Meade TL, Meyers MP, Dupont EL, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008;14(3):250–4.

    Article  PubMed  Google Scholar 

  17. Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CE, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16(5):1143–7.

    Article  PubMed  Google Scholar 

  18. Mondi MM, Cuenca RE, Ollila DW, Stewart JH, Levine EA. Sentinel lymph node biopsy during pregnancy: initial clinical experience. Ann Surg Oncol. 2007;14(1):218–21.

    Article  PubMed  Google Scholar 

  19. Broer N, Buonocore S, Goldberg C, Truini C, Faries MB, Narayan D, et al. A proposal for the timing of management of patients with melanoma presenting during pregnancy. J Surg Oncol. 2012;106(1):36–40. This is an important work to refer to when treating pregnant patients with melanoma.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Gziri MM, Han SN, Amant F. Use of general anesthesia and sentinel node procedure during pregnancy. J Surg Oncol. 2012;106(8):1008. This is a good reference for the safety of SLNB in pregnant women.

    Article  PubMed  Google Scholar 

  21. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005;190(3):467–73.

    Article  PubMed  Google Scholar 

  22. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. An important paper with recent results regarding the importance of SLNB procedure in malignant melanoma.

    Article  CAS  PubMed  Google Scholar 

  23. Oto A, Ernst R, Jesse MK, Chaljub G, Saade G. Magnetic resonance imaging of the chest, abdomen, and pelvis in the evaluation of pregnant patients with neoplasms. Am J Perinatol. 2007;24(4):243–50.

    Article  PubMed  Google Scholar 

  24. Egberts F, Lischner S, Russo P, Kampen WU, Hauschild A. Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risks for the fetus? J Dtsch Dermatol Ges. 2006;4(9):717–20.

    Article  PubMed  Google Scholar 

  25. Wheatley K, Ives N, Hancock B, Gore M, Eggermont A, Suciu S. Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials. Cancer Treat Rev. 2003;29(4):241–52.

    Article  CAS  PubMed  Google Scholar 

  26. Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V. Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev. 2013;6, CD008955.

    PubMed  Google Scholar 

  27. Maleka A, Enblad G, Sjörs G, Lindqvist A, Ullenhag GJ. Treatment of metastatic malignant melanoma with vemurafenib during pregnancy. J Clin Oncol. 2013;31(11):e192–3.

    Article  PubMed  Google Scholar 

  28. NF. Beitrage zur pathologie des krebeses. Virchows archives (pathologic anatomy); 1866 p. 30–4.

  29. Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol. 2003;21(11):2179–86.

    Article  PubMed  Google Scholar 

  30. Mathew M, Sheik S, Rao K, Burney IA, Sawhney S, Al-Hamdani A. Metastatic malignant melanoma during pregnancy: case report and a review of the literature. Sultan Qaboos Univ Med J. 2009;9(1):79–83.

    PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

S Merims, S Frank, T Yablonski-Peretz, and M Lotem all declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Sharett Institute of Oncology, Hadassah - Hebrew University Medical Center, P.O. Box 12000, 9112001, Jerusalem, Israel

    Sharon Merims, Stephen Frank, Tamar Yablonski-Peretz & Michal Lotem

  2. Sharett Institute of Oncology, Hadassah Medical Organization, P.O. Box 12000, 91120, Jerusalem, Israel

    Stephen Frank, Tamar Yablonski-Peretz & Michal Lotem

Authors
  1. Sharon Merims
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Stephen Frank
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Tamar Yablonski-Peretz
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Michal Lotem
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Sharon Merims.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merims, S., Frank, S., Yablonski-Peretz, T. et al. Melanoma in Pregnancy: Therapeutic Challenges. Curr Derm Rep 3, 149–152 (2014). https://doi.org/10.1007/s13671-014-0082-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13671-014-0082-1

Keywords